Vertex Pharmaceuticals (VRTX)

Long-Term Debt

$1.98B

Quarterly · Period ending: · USD

VRTX logo

VRTX Long-Term Debt

Latest reported$3.80B
VRTX FY Long-Term Debt ($2.40M → $3.80B)
High-resolution chart · PNG

VRTX long-term debt history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Long-Term Debt — Annual fiscal periods (USD)
Period endingLong-Term Debt (USD)
3,799,700,000
1,657,200,000
724,700,000
810,300,000
887,200,000
889,500,000
622,868,000
581,550,000
583,902,000
521,335,000
739,397,000
792,935,000
489,691,000
683,201,000
455,950,000
400,000,000
121,765,000
287,500,000
0
19,997,000
0
334,997,000
359,188,000
325,944,000
323,026,000
357,269,000
4,693,000
7,000,000
5,900,000
5,600,000
4,900,000
4,700,000
4,200,000
3,300,000
2,100,000
2,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.